ConductScience.org, home

Paper1901649

Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.

Takeyama M and 6 others. Pharm Res, 1991. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors. Papers, record 1901649. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1901649

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhanced bioavailability of subcutaneously injected insulin by pretreatment with ointment containing protease inhibitors.
PubMed
Journal
Pharm Res
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.95
iCite
Revised in PubMed
2026-10-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Takeyama MM
2Ishida TT
3Kokubu NN
4Komada FF
5Iwakawa SS
6Okumura KK
7Hori RR

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
InsulinMajor topic
Protease InhibitorsMajor topic
Administration, Topical
Adult
Animals
Benzamidines
Biological Availability
Gabexate
Guanidines
Heart Arrest, Induced
Humans
Injections, Subcutaneous
Iodine Radioisotopes
Male
Mice
Mice, Hairless
Ointments
Rats
Rats, Inbred Strains

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13927313Simultaneous determination of gabexate mesilate (Foy) and its catabolite in plasma and whole blood by reverse-phase high-performance liquid chromatography.Pharm Acta Helv1985https://conductscience.org/library/papers/3927313PubMed
2488572Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.Diabetologia1979https://conductscience.org/library/papers/488572PubMed
34032239[Stability studies on nafamstat mesilate in aqueous solution. I. Kinetic studies in various pH and temperature conditions].Yakugaku Zasshi1985https://conductscience.org/library/papers/4032239PubMed
424271350Protein drugs: a revolution in therapy?Pharm Res1986https://conductscience.org/library/papers/24271350PubMed
54241908Diabetogenic action of streptozotocin: relationship of dose to metabolic response.J Clin Invest1969https://conductscience.org/library/papers/4241908PubMed
614036480Specific determination of blood glucose with o-toluidine.Clin Chim Acta1962https://conductscience.org/library/papers/14036480PubMed
76155578Resistance against subcutaneous insulin successfully managed with aprotinin.Lancet1980https://conductscience.org/library/papers/6155578PubMed
83891962Fate of porcine and human insulin at the subcutaneous injection site. I. Degradation and absorption of insulins in the rat.J Pharmacobiodyn1985https://conductscience.org/library/papers/3891962PubMed
91270578Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects.J Clin Endocrinol Metab1976https://conductscience.org/library/papers/1270578PubMed
106482087Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.Jpn J Pharmacol1984https://conductscience.org/library/papers/6482087PubMed
112409262Fate of porcine and human insulin at the subcutaneous injection site. II. In vitro degradation of insulins in the subcutaneous tissue of the rat.J Pharmacobiodyn1985https://conductscience.org/library/papers/2409262PubMed
127000596Matched glucose responses to insulin administered subcutaneously and intravenously. Evidence for subcutaneous inactivation of insulin.Diabetologia1980https://conductscience.org/library/papers/7000596PubMed
137019707Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.N Engl J Med1981https://conductscience.org/library/papers/7019707PubMed
142682592Enhanced bioavailability of subcutaneously injected insulin coadministered with collagen in rats and humans.Pharm Res1989https://conductscience.org/library/papers/2682592PubMed
154259678Inhibitory effects of -guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin.Biochim Biophys Acta1972https://conductscience.org/library/papers/4259678PubMed
166553561New synthetic inhibitor to the alternative complement pathway.Immunology1983https://conductscience.org/library/papers/6553561PubMed
177391939Permeation of hairless mouse skin I: Experimental methods and comparison with human epidermal permeation by alkanols.J Pharm Sci1980https://conductscience.org/library/papers/7391939PubMed
186191020Pharmaceutical approach to subcutaneous dosage forms of insulin.J Pharm Sci1983https://conductscience.org/library/papers/6191020PubMed
19700273Mobilization of subcutaneously injected tritiated insulin in rats: effects of muscular exercise.Diabetologia1978https://conductscience.org/library/papers/700273PubMed
206073660The specific inactivation of trypsin by ethyl p-guanidinobenzoate.J Biol Chem1967https://conductscience.org/library/papers/6073660PubMed

See all 31 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
33942169A Two-Pore Physiologically Based Pharmacokinetic Model to Predict Subcutaneously Administered Different-Size Antibody/Antibody Fragments.AAPS J2021https://conductscience.org/library/papers/33942169PubMed
31817205Understanding Inter-Individual Variability in Monoclonal Antibody Disposition.Antibodies (Basel)2019https://conductscience.org/library/papers/31817205PubMed
31408633Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.J Pharm Sci2020https://conductscience.org/library/papers/31408633PubMed
28707164Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers.Pharm Res2017https://conductscience.org/library/papers/28707164PubMed
27327034A Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity.Bioconjug Chem2016https://conductscience.org/library/papers/27327034PubMed
22707818Noninvasive routes of proteins and peptides drug delivery.Indian J Pharm Sci2011https://conductscience.org/library/papers/22707818PubMed
12916897Influence of absorption promoters on pulmonary insulin bioactivity.AAPS PharmSciTech2003https://conductscience.org/library/papers/12916897PubMed
11785686Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats.Pharm Res2001https://conductscience.org/library/papers/11785686PubMed
9755890Permeability characteristics of tetragastrins across intestinal membranes using the Caco-2 monolayer system: comparison between acylation and application of protease inhibitors.Pharm Res1998https://conductscience.org/library/papers/9755890PubMed
7937534Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats.Pharm Res1994https://conductscience.org/library/papers/7937534PubMed
2128896Improvement in wound healing by epidermal growth factor (EGF) ointment. I. Effect of nafamostat, gabexate, or gelatin on stabilization and efficacy of EGF.Pharm Res1990https://conductscience.org/library/papers/2128896PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1901649

GET https://conductscience.org/api/papers/v1/1901649/references?page=2